About vosoritide
C-type natriuretic peptide analogue
Used for
- Promotes growth in children with achondroplasia whose growth plates remain open.
Usual adult dose
Not indicated for adults.
Usual dose in children
Once daily under the skin: 15 micrograms/kg for children under 5 years; 30 micrograms/kg from age 5 years, adjusted for weight and local product guidance.
Common side effects
- Vomiting
- Injection-site reactions
- Low blood pressure
- Dizziness
Important warnings
- Can lower blood pressure, especially after injection; maintain adequate fluid intake.
- Use only while growth plates are open.
- Monitor growth and adjust dosing as weight changes.
- Avoid use during pregnancy unless clearly necessary.
Pregnancy
There is limited information; use is generally avoided during pregnancy.
Breastfeeding
It is unknown whether vosoritide passes into breast milk; breastfeeding safety is not established.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.